2m 2m 2m 2m 2m 2m 2m
Niagen Biosci (NAGE)
NASDAQ
$3.43-$0.010 (-0.29%)
Price as of Jun 03, 2026 7:59 PM EDT- $307.4MMarket Cap
- -70.64%1-Year Change
- BiotechnologyIndustry
Niagen Biosci (NAGE)
$3.43-$0.010 (-0.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 129.4M +29.95% | 99.6M +19.18% | 83.6M +15.99% | 72.0M +6.82% | |
Cost of Revenue | 46.2M +21.63% | 38.0M +15.92% | 32.8M +12.09% | 29.3M +12.69% | |
Gross Profit | 83.2M +35.08% | 61.6M +21.28% | 50.8M +18.65% | 42.8M +3.15% | |
Sales and Marketing Expense | 35.5M +20.49% | 29.5M +11.46% | 26.4M -6.62% | 28.3M -0.14% | |
Research and Development Expense | -6.3M +5.22% | -6.0M +21.34% | -5.0M +2.74% | -4.8M +25.94% | |
Depreciation and Amortization Expense | 173,000 +14.57% | 151,000 -4.43% | 158,000 -15.05% | 186,000 -17.33% | |
Total Operating Expenses | 66.9M +24.23% | 53.9M -4.47% | 56.4M -8.21% | 61.4M -10.41% | |
Operating Profit | 16.3M +110.70% | 7.7M +237.99% | -5.6M -69.94% | -18.6M -31.19% | |
Interest Income | 2.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 2.1M N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 1.9M +69.44% | 1.1M +70.80% | 661,000 +21,933.33% | 3,000 -94.55% | |
Income before Taxes | 18.2M +105.44% | 8.9M +258.15% | -5.6M -69.94% | -18.6M -31.19% | |
Income Taxes | 810,000 +165.57% | 305,000 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 17.4M +103.30% | 8.6M +273.15% | -4.9M -70.15% | -16.5M -39.03% | |
Net Income from Continuing Operations Applicable to Common | 18.2M +105.44% | 8.9M +279.32% | -4.9M -70.15% | -16.5M -39.03% | |
Basic EPS and Net Income | 0.22 +100.00% | 0.11 +257.14% | -0.07 -70.83% | -0.24 -40.00% | |
Diluted EPS and Net Income | 0.20 +81.82% | 0.11 +257.14% | -0.07 -70.83% | -0.24 -40.00% | |
Basic Weighted Average Shares | 79.2M +4.28% | 75.9M +1.26% | 75.0M +7.54% | 69.7M +3.79% | |
Diluted Weighted Average Shares | 85.4M +9.36% | 78.1M +4.19% | 75.0M +7.54% | 69.7M +3.79% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 64.8M +45.07% | 44.7M +63.44% | 27.3M +33.68% | 20.4M -27.56% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 64.8M +45.07% | 44.7M +63.44% | 27.3M +33.68% | 20.4M -27.56% | |
Total Current Assets | 96.8M +51.02% | 64.1M +29.41% | 49.5M +6.37% | 46.6M -4.78% | |
Accumulated Depreciation | 5.8M -0.17% | 5.8M +6.54% | 5.4M +18.80% | 4.6M +0.22% | |
Property and Plant and Equipment and Net | 1.3M -23.04% | 1.7M -19.56% | 2.1M -23.65% | 2.8M -6.79% | |
Total Long-Term Assets | 425,000 +15.49% | 368,000 -3.92% | 383,000 -22.94% | 497,000 -31.26% | |
Total Assets | 106.4M +55.84% | 68.3M +24.22% | 55.0M +1.68% | 54.1M -6.54% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 2.1M N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 19.9M +10.98% | 17.9M -12.97% | 20.6M +15.41% | 17.9M +1.45% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10.0M +134.99% | 4.2M -27.89% | 5.9M -21.62% | 7.5M -11.84% | |
Total Liabilities | 29.9M +34.66% | 22.2M -16.31% | 26.5M +4.42% | 25.4M -2.79% | |
Retained Earnings | -164.5M -9.56% | -181.9M -4.49% | -190.5M +2.68% | -185.5M +9.79% | |
Total Stockholders Equity | 76.5M +66.04% | 46.1M +61.98% | 28.5M -0.75% | 28.7M -9.63% | |
Total Shares Outstanding | 79.7M +3.08% | 77.3M +3.13% | 75.0M +0.56% | 74.6M +9.45% | |
Cash Flow | |||||
Cash from Operating Activities | 13.5M +11.52% | 12.1M +70.14% | 7.1M +147.14% | -15.1M -37.52% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -292,000 +104.20% | -143,000 0.00% | -143,000 -57.19% | -334,000 -18.34% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.9M +28.81% | 5.4M +6,065.56% | -90,000 -101.18% | 7.7M -78.79% | |
Financials Ratio | |||||
Gross Margin | 64.28% +3.95% | 61.84% +1.76% | 60.76% +2.30% | 59.40% -3.44% | |
Operating Margin | 12.58% +62.15% | 7.76% +215.78% | -6.70% -74.09% | -25.85% -35.59% | |
Return on Assets | 19.90% +43.43% | 13.88% +253.17% | -9.06% -69.36% | -29.56% -47.58% | |
Return on Equity | 28.35% +23.59% | 22.94% +232.68% | -17.29% -68.44% | -54.77% -51.39% | |
Revenue Growth | 29.95% +56.15% | 19.18% +19.95% | 15.99% +134.39% | 6.82% -50.66% | |
Current Ratio | 4.86 +36.08% | 3.57 +48.69% | 2.40 -7.83% | 2.61 -6.14% | |
Cash Ratio | 3.25 +30.72% | 2.49 +87.80% | 1.33 +15.83% | 1.14 -28.60% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow